Manager, Financial Reporting

Tonix Pharmaceuticals; Berkeley Heights (NJ); On-site; USD 100,000 - 150,000; Full time

Benefits offered by this job

Medical, Dental & Vision Insurance

401k with company match

Stock options

Paid Time Off

Job summary

Tonix Pharmaceuticals is seeking an experienced Manager, Financial Reporting to lead the external reporting process and SEC compliance. You will prepare and review SEC filings, maintain accounting memos, and partner with finance, legal, IR, and auditors to ensure accurate reporting.

The ideal candidate has deep SEC reporting expertise, strong technical accounting knowledge, and prior Big Four public accounting experience.

Qualifications

• Bachelor’s degree in Accounting or Finance required; Master’s degree preferred.
• Active CPA license required.
• 5+ years of progressive accounting and financial reporting experience.
• Minimum 3–5 years of direct SEC reporting experience (Forms 10-K, 10-Q, 8-K, Proxy Statements).
• Big Four public accounting experience required.
• Experience drafting technical accounting memoranda and position papers.

Responsibilities

• Lead preparation, review, and timely filing of all SEC reports (10-K, 10-Q, 8-K, proxies).
• Prepare SEC reporting support schedules and disclosure checklists.
• Draft and maintain technical accounting memos under U.S. GAAP and SEC regs.
• Research complex accounting issues and emerging standards; write memos.
• Coordinate information with internal stakeholders and external auditors.
• Support SOX compliance and internal control documentation.

Skills

Attention to detail

Excellent communication

Deadline management

GAAP knowledge

Education

Bachelor’s degree in Accounting or Finance

Master’s degree preferred

Tools

Microsoft Excel

SEC reporting tools

ERP systems

Job description

Tonix Pharmaceuticals* is a fully integrated, commercial-stage biotechnology company focused on central nervous system (CNS) and immunology treatments in areas of high unmet medical need. TONMYA® (cyclobenzaprine HCl sublingual tablets 2.8 mg) is the first new treatment for fibromyalgia in adults in more than 15 years. Tonix’s CNS commercial infrastructure supports its marketed products, including its acute migraine products, Zembrace® Symtouch® (sumatriptan injection 3 mg) and Tosymra® (sumatriptan nasal spray 10 mg). Tonix is investigating TONMYA® in Phase 2 clinical trials to evaluate its potential in major depressive disorder and acute stress disorder/acute stress reaction. Tonix is also advancing a pipeline of immunology programs, including TNX-4800, a Phase 2 ready long‑acting human anti-Borrelia OspA monoclonal antibody (mAb) for the prevention of Lyme disease in the U.S., and TNX-1500, a Phase 2 ready third‑generation CD40 ligand inhibitor for the prevention of kidney transplant rejection. In addition, the Company is progressing TNX-2900 (intranasal potentiated oxytocin), which is Phase 2 ready for the treatment of Prader‑Willi syndrome, a rare disease. To learn more, visit www.tonixpharma.com and follow the Company on LinkedIn and X.

• Tonix’s product development candidates are investigational new drugs or biologics; their efficacy and safety have not been established and have not been approved for any indication.

Position Overview

Tonix Pharmaceuticals is seeking an experienced Manager, Financial Reporting to lead and manage the Company's external financial reporting process and SEC compliance activities. This role will be responsible for preparing and reviewing SEC filings, maintaining technical accounting documentation, supporting ad hoc reporting and analysis, and partnering cross‑functionally with finance, legal, investor relations, and external auditors. The ideal candidate possesses deep SEC reporting expertise, strong technical accounting knowledge, and prior Big Four public accounting experience.

Key Responsibilities

• Lead the preparation, review, and timely filing of all SEC reports, including Forms 10-K, 10-Q, 8-K, Proxy Statements, Section 16 filings, and other required disclosures.
• Prepare and maintain SEC reporting support schedules, disclosure checklists, and reporting calendars.
• Draft, update, and maintain technical accounting memos documenting the Company's accounting positions and conclusions under U.S. GAAP and SEC regulations.
• Research and evaluate complex accounting issues, new accounting standards, and SEC reporting requirements and write technical memos.
• Coordinate information gathering and review processes with internal stakeholders and external auditors.
• Manage XBRL tagging review and support SEC filing submissions.
• Assist with quarterly earnings support materials and investor reporting requirements.
• Support the annual audit and quarterly review processes, including preparation of auditor deliverables.
• Prepare ad hoc financial analyses, board reporting materials, and management presentations.
• Support SOX compliance activities and internal control documentation related to financial reporting.
• Monitor emerging accounting and SEC developments and assess potential impacts to the Company.
• Drive process improvements to enhance reporting accuracy, efficiency, and compliance.

Qualifications

• Bachelor’s degree in Accounting or Finance required; Master’s degree preferred.
• Active Certified Public Accountant (CPA) license required.
• Advanced Microsoft Excel skills and proficiency with SEC reporting tools.
• Excellent written and verbal communication skills with strong attention to detail.
• Ability to manage multiple deadlines in a fast‑paced public company environment.
• Strong knowledge of U.S. GAAP, SEC regulations, and public company reporting requirements
• 5+ years of progressive accounting and financial reporting experience.
• Minimum 3–5 years of direct SEC reporting experience with responsibility for Forms 10-K, 10-Q, and Proxy Statements.
• Big Four public accounting experience required.
• Experience preparing technical accounting memoranda and accounting position papers.

Preferred Qualifications

• Life sciences, biotechnology, pharmaceutical, or healthcare industry experience.
• Experience with equity accounting, stock compensation, and SEC disclosure requirements.
• Experience with implementation of SEC reporting software and or ERP system
• Prior experience supporting SOX compliance and internal controls over financial reporting.

Salary Range: $100,000 USD - $150,000 USD

Please note that Tonix does not offer sponsorship for this role.

Compensation & Benefits

• Medical, Dental & Vision Insurance, Basic and Voluntary Life and AD&D Insurance, Short- and Long-Term Disability Insurance, Flexible Spending Accounts, Health Savings Account, and Employee Assistance Programs
• Pet Insurance
• Retirement Savings 401k with company match and annual discretionary stock options
• Generous Paid Time Off, Sick Time, & Paid Holidays
• Career Development and Training

Tonix provides equal employment opportunities (EEO) to all employees and applicants for employment without regard to race, color, religion, sex, national origin, age, genetics, or any other characteristic protected by law. In addition to federal law requirements, Tonix complies with applicable state and local laws governing nondiscrimination in employment. This policy applies to all terms and conditions of employment, including recruiting, hiring, placement, promotion, termination, layoff, recall, transfers, leaves of absence, compensation, and training. Tonix expressly prohibits any form of workplace harassment based on race, color, religion, gender, sexual orientation, gender identity or expression, national origin, age, genetic, information, disability, veteran status, or any other characteristic protected by law.